Literature DB >> 6812742

New prospects for luteinising hormone releasing hormone as a contraceptive and therapeutic agent.

H M Fraser.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6812742      PMCID: PMC1500357          DOI: 10.1136/bmj.285.6347.990

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  13 in total

1.  Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen.

Authors:  N B Loudon; M Foxwell; D M Potts; A L Guild; R V Short
Journal:  Br Med J       Date:  1977-08-20

Review 2.  Extrapituitary actions of gonadotropin-releasing hormone.

Authors:  A J Hsueh; P B Jones
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

3.  Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.

Authors:  R Linde; G C Doelle; N Alexander; F Kirchner; W Vale; J Rivier; D Rabin
Journal:  N Engl J Med       Date:  1981-09-17       Impact factor: 91.245

4.  Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.

Authors:  C Bergquist; S J Nillius; L Wide; A Lindgren
Journal:  Fertil Steril       Date:  1981-09       Impact factor: 7.329

5.  Effect of oestrogen on gonadotrophin release in stumptailed monkeys (Macaca arctoides) treated chronically with an agonist analogue of luteinizing hormone releasing hormone.

Authors:  H M Fraser
Journal:  J Endocrinol       Date:  1981-12       Impact factor: 4.286

6.  Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: a new biological effect.

Authors:  K Sundaram; Y Q Cao; N G Wang; C W Bardin; J Rivier; W Vale
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

7.  Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist.

Authors:  S W Lamberts; J M Timmers; R Oosterom; T Verleun; F H de Jong
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

8.  Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men.

Authors:  N Faure; F Labrie; A Lemay; A Bélanger; Y Gourdeau; B Laroche; G Robert
Journal:  Fertil Steril       Date:  1982-03       Impact factor: 7.329

9.  "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.

Authors:  D R Meldrum; R J Chang; J Lu; W Vale; J Rivier; H L Judd
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

10.  Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.

Authors:  F Comite; G B Cutler; J Rivier; W W Vale; D L Loriaux; W F Crowley
Journal:  N Engl J Med       Date:  1981-12-24       Impact factor: 91.245

View more
  2 in total

1.  Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.

Authors:  D L Healy; H M Fraser; S L Lawson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

2.  Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.

Authors:  J G Klijn; F H de Jong; M A Blankenstein; R Docter; J Alexieva-Figusch; J Blonk-van der Wijst; S W Lamberts
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.